vs
NRX Pharmaceuticals, Inc.（NRXP）与Palladyne AI Corp.（PDYN）财务数据对比。点击上方公司名可切换其他公司
Palladyne AI Corp.的季度营收约是NRX Pharmaceuticals, Inc.的1.7倍（$1.7M vs $983.0K），NRX Pharmaceuticals, Inc.净利率更高（36.7% vs -89.9%，领先126.6%）
NRX Pharmaceuticals是一家处于临床阶段的生物制药企业，专注于开发针对中枢神经系统疾病的创新疗法，覆盖罕见神经精神类适应症，核心市场以美国为主，核心在研产品面向有未满足医疗需求的重度情绪与创伤相关疾病患者。
Palladyne AI Corp是一家美国企业，其前身1983年成立时名为萨科斯研究公司，企业长期以来以机器人开发为核心业务。2023年，公司调整业务方向，专注开发适用于机器人场景的人工智能软件，终止了硬件业务，并于2024年3月正式更名为现用名。
NRXP vs PDYN — 直观对比
营收规模更大
PDYN
是对方的1.7倍
$983.0K
净利率更高
NRXP
高出126.6%
-89.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $983.0K | $1.7M |
| 净利润 | $361.0K | $-1.5M |
| 毛利率 | — | 15.6% |
| 营业利润率 | — | -560.7% |
| 净利率 | 36.7% | -89.9% |
| 营收同比 | — | 118.3% |
| 净利润同比 | 104.0% | 97.2% |
| 每股收益（稀释后） | — | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NRXPPDYN
| Q4 25 | $983.0K | $1.7M | ||
| Q3 25 | $242.0K | $860.0K | ||
| Q2 25 | $0 | $1.0M | ||
| Q1 25 | $0 | $1.7M | ||
| Q4 24 | — | $761.0K | ||
| Q3 24 | $0 | $871.0K | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $3.4M |
净利润NRXPPDYN
| Q4 25 | $361.0K | $-1.5M | ||
| Q3 25 | $-5.9M | $-3.7M | ||
| Q2 25 | $-17.6M | $-7.5M | ||
| Q1 25 | $-5.5M | $22.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.6M | $-7.1M | ||
| Q2 24 | — | $-5.3M | ||
| Q1 24 | — | $-7.2M |
毛利率NRXPPDYN
| Q4 25 | — | 15.6% | ||
| Q3 25 | 59.9% | 46.4% | ||
| Q2 25 | — | 53.3% | ||
| Q1 25 | — | 79.4% | ||
| Q4 24 | — | 27.2% | ||
| Q3 24 | — | 45.0% | ||
| Q2 24 | — | 79.0% | ||
| Q1 24 | — | 45.2% |
营业利润率NRXPPDYN
| Q4 25 | — | -560.7% | ||
| Q3 25 | -1662.8% | -937.8% | ||
| Q2 25 | — | -797.4% | ||
| Q1 25 | — | -405.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -838.0% | ||
| Q2 24 | — | -213.3% | ||
| Q1 24 | — | -213.7% |
净利率NRXPPDYN
| Q4 25 | 36.7% | -89.9% | ||
| Q3 25 | -2433.9% | -434.9% | ||
| Q2 25 | — | -737.6% | ||
| Q1 25 | — | 1330.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -814.7% | ||
| Q2 24 | — | -196.2% | ||
| Q1 24 | — | -210.1% |
每股收益（稀释后）NRXPPDYN
| Q4 25 | — | $-0.02 | ||
| Q3 25 | — | $-0.09 | ||
| Q2 25 | — | $-0.20 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.27 | ||
| Q2 24 | — | $-0.20 | ||
| Q1 24 | — | $-0.28 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $7.8M | $47.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-15.9M | $74.7M |
| 总资产 | $13.0M | $95.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NRXPPDYN
| Q4 25 | $7.8M | $47.1M | ||
| Q3 25 | $7.2M | $57.1M | ||
| Q2 25 | $2.9M | $62.7M | ||
| Q1 25 | $5.5M | $46.6M | ||
| Q4 24 | — | $40.1M | ||
| Q3 24 | $1.6M | $21.3M | ||
| Q2 24 | — | $25.8M | ||
| Q1 24 | — | $31.8M |
股东权益NRXPPDYN
| Q4 25 | $-15.9M | $74.7M | ||
| Q3 25 | $-25.8M | $51.8M | ||
| Q2 25 | $-35.6M | $53.8M | ||
| Q1 25 | $-25.2M | $28.3M | ||
| Q4 24 | — | $-9.5M | ||
| Q3 24 | $-18.8M | $23.4M | ||
| Q2 24 | — | $29.8M | ||
| Q1 24 | — | $34.2M |
总资产NRXPPDYN
| Q4 25 | $13.0M | $95.7M | ||
| Q3 25 | $15.0M | $72.9M | ||
| Q2 25 | $4.8M | $78.3M | ||
| Q1 25 | $7.6M | $63.3M | ||
| Q4 24 | — | $56.3M | ||
| Q3 24 | $4.5M | $38.7M | ||
| Q2 24 | — | $45.1M | ||
| Q1 24 | — | $50.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.7M | $-8.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-8.7M |
| 自由现金流率自由现金流/营收 | — | -526.2% |
| 资本支出强度资本支出/营收 | — | 14.2% |
| 现金转化率经营现金流/净利润 | -10.29× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NRXPPDYN
| Q4 25 | $-3.7M | $-8.5M | ||
| Q3 25 | $-2.9M | $-6.3M | ||
| Q2 25 | $-4.0M | $-5.3M | ||
| Q1 25 | $-3.5M | $-7.5M | ||
| Q4 24 | — | $-22.6M | ||
| Q3 24 | $-2.3M | $-4.5M | ||
| Q2 24 | — | $-5.8M | ||
| Q1 24 | — | $-7.2M |
自由现金流NRXPPDYN
| Q4 25 | — | $-8.7M | ||
| Q3 25 | — | $-6.7M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-7.6M | ||
| Q4 24 | — | $-22.9M | ||
| Q3 24 | — | $-4.5M | ||
| Q2 24 | — | $-5.9M | ||
| Q1 24 | — | $-7.3M |
自由现金流率NRXPPDYN
| Q4 25 | — | -526.2% | ||
| Q3 25 | — | -776.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -445.0% | ||
| Q4 24 | — | -3008.1% | ||
| Q3 24 | — | -517.8% | ||
| Q2 24 | — | -218.9% | ||
| Q1 24 | — | -212.1% |
资本支出强度NRXPPDYN
| Q4 25 | — | 14.2% | ||
| Q3 25 | — | 44.7% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 5.4% | ||
| Q4 24 | — | 34.8% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | 5.3% | ||
| Q1 24 | — | 1.8% |
现金转化率NRXPPDYN
| Q4 25 | -10.29× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.33× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
